Lindbrook Capital’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-19
| Closed | -$427 | – | 2872 |
|
|
2024
Q3 | $427 | Sell |
19
-2
| -10% | -$45 | ﹤0.01% | 2707 |
|
|
2024
Q2 | $438 | Buy |
+21
| New | +$438 | ﹤0.01% | 2653 |
|
|
2023
Q4 | – | Sell |
-333
| Closed | -$2.62K | – | 2790 |
|
|
2023
Q3 | $2.62K | Buy |
333
+159
| +91% | +$1.25K | ﹤0.01% | 2027 |
|
|
2023
Q2 | $1.74K | Sell |
174
-129
| -43% | -$1.29K | ﹤0.01% | 2205 |
|
|
2023
Q1 | $2.69K | Buy |
303
+144
| +91% | +$1.28K | ﹤0.01% | 2115 |
|
|
2022
Q4 | $1.75K | Buy |
159
+34
| +27% | +$373 | ﹤0.01% | 2284 |
|
|
2022
Q3 | $2K | Hold |
125
| – | – | ﹤0.01% | 2102 |
|
|
2022
Q2 | $2K | Buy |
125
+9
| +8% | +$144 | ﹤0.01% | 2012 |
|
|
2022
Q1 | $2K | Buy |
+116
| New | +$2K | ﹤0.01% | 2037 |
|